The purpose of this paper is to present a case of congenital pseudohypoparathyroidism, late diagnosed in a 22-year-old patient.
The patient’s history revealed hypocalcaemia, diagnosed at birth and persistent despite the treatment with calcium. At 8 years old, the patient is diagnosed with epilepsy and receives treatment with Levetiracetam and Oxcarbazepine; at 12 years old she is diagnosed with dilatative cardiomyopathy and receives treatment with Spironolactone and Glycosides. At 22 years old, she visits our Internal Medicine Department with the suspicion of polymyositis and psoriasis. Clinical examination shows armonic short stature, fourth finger hypoplasia, laboratory findings show severe hypocalcaemia, the hand X-ray - third and fourth metacarpal hypoplasia, immunological tests were negative. All data leads to the diagnosis of congenital disease, and given the history of the patient and the evolution of the clinical manifestations we presume hypoparathyroidism or pseudohypoparathyroidism, therefore PTH is dosed – with normal values, and the diagnosis of congenital pseudohypoparathyroidism is established. The patient was referred to endocrinology, where genetic tests were performed to confirm the diagnosis.
In conclusion, in the absence of multiple pathology integration into a single disease, the diagnosis of the genetic disease is delayed. Therefore, it is important to have a comprehensive approach and collaboration between different specialties to establish the correct diagnosis.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Goltzman D Cole DEC. Hypoparathyroidism. In: Primer on the metabolic bone diseases and disorders of mineral metabolism 6th ed Favus MJ (Ed) American Society of Bone and Mineral Research Washington DC 2006.p.216.
2. Rita Rastogi Norman J. Beauchamp Paul W. Ladenson Calcification of the Basal Ganglia in Chronic Hypoparathyroidism The Journal of Clinical Endocrinology & Metabolism Volume 88 Issue 4 1 April 2003 Pages 1476–1477.
3. Rubin MR Levine MA. Hypoparathyroidism and pseudohypoparathyroidism. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 8th ed Rosen CJ (Ed) American Society of Bone and Mineral Research Ames Iowa 2013. p.579.
4. New Directions in Treatment of Hypoparathyroidism. Tabacco G Bilezikian JP. Endocrinol Metab Clin North Am. 2018;47(4):901.
5. Sikjaer T. Rejnmark L. Rolighed L. Heickendorff L. Mosekilde L. and (2011) The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: A randomized placebo-controlled study. J Bone Miner Res 26: 2358-2370. doi:10.1002/jbmr.470
6. Defect of receptor-cyclase coupling protein in psudohypoparathyroidism. Farfel Z Brickman AS Kaslow HR Brothers VM Bourne HR. N Engl J Med. 1980;303(5):237.
7. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Levine MA Downs RW Jr Moses AM Breslau NA Marx SJ Lasker RD Rizzoli RE Aurbach GD Spiegel AM. Am J Med. 1983;74(4):545.
8. FARFEL Z FRIEDMAN E. Mental Deficiency in Pseudohypoparathyroidism Type I Is Associated with Ns-Protein Deficiency. Ann Intern Med. 1986;105:197–199. doi: 10.7326/0003-4819-105-2-197.
9. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. Murray TM Rao LG Wong MM Waddell JP McBroom R Tam CS Rosen F Levine MA. J Bone Miner Res. 1993;8(1):83.
10. Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. Farfel Z Brothers VM Brickman AS Conte F Neer R Bourne HR. Proc Natl Acad Sci U S A. 1981;78(5):3098.
11. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3. Furukawa Y Sohn H Unakami H Yumita S. Contrib Nephrol. 1980;22:68.